The evidence base for prophylactic antibiotics in patients receiving extracorporeal membrane oxygenation

ASAIO Journal

Volumn 62, Issue 1, 2016, Pages 6-10

  O'Horo, John C ^a   Cawcutt, Kelly A ^a   De Moraes, Alice Gallo ^a   Sampathkumar, Priya ^a   Schears, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antibiotic Prophylaxis; Bacterial Infections; Mycoses; Preventive Therapy; Systematic Review

Indexed keywords

ANTIBIOTICS; OXYGENATION; RESPIRATORY THERAPY;

CHLORHEXIDINE; EXTRACORPOREAL MEMBRANE OXYGENATION; INCLUSION AND EXCLUSIONS; MEDLINE;

PATIENT TREATMENT;

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BLOODSTREAM INFECTION; EXTRACORPOREAL OXYGENATION; HOSPITAL INFECTION; HUMAN; MICROBIOLOGY; MYCOSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SURGICAL INFECTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY TRACT INFECTION; ADVERSE EFFECTS; CROSS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS;

EID: 84952715838     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000287     Document Type: Review

References (17)

1. Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P; Extracorporeal Life Support Organization Task Force on Infections, Extracorporeal Membrane Oxygenation: Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 12: 277-281, 2011.
2. Hsu MS, Chiu KM, Huang YT, Kao KL, Chu SH, Liao CH: Risk factors for nosocomial infection during extracorporeal membrane oxygenation. J Hosp Infect 73: 210-216, 2009.
3. Extracorporeal Life Support Organization. ELSO ID Task Force Recommendation Summary [Internet], Ann Arbor, MI, USA, 2012, p. 8. Available at: http://www.elso.org/downloads/resources/committees/infectious-disease-And-Antibiotic/ELSO-ID-Task-Force-Recommendations-Summary.pdf. Accessed on July 23, 2014.
4. Moher D, Altman DG, Liberati A, Tetzlaff J: PRISMA statement. Epidemiology 22: 128, author reply 128, 2011.
5. Gardner AH, Prodhan P, Stovall SH, et al: Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support. J Thorac Cardiovasc Surg 143: 689-695, 2012.
6. Gardner AH, Prodhan P, Stovall SH, et al: Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support. J Thorac Cardiovasc Surg 143: 689-695, 2012.
7. Schutze GE, Heulitt MJ: Infections during extracorporeal life support. J Pediatr Surg 30: 809-812, 1995.
8. Steiner CK, Stewart DL, Bond SJ, Hornung CA, McKay VJ: Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation. J Pediatr Surg 36: 487-492, 2001.
9. ONeill JM, Schutze GE, Heulitt MJ, Simpson PM, Taylor BJ: Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med 27: 1247-1253, 2001.
10. Brown KL, Ridout DA, Shaw M, et al: Healthcare-Associated infection in pediatric patients on extracorporeal life support: the role of multidisciplinary surveillance. Pediatr Crit Care Med 7: 546-550, 2006.
11. Nagappala K, Gonzalez R, Lelli J, Langenburg S. Pediatric extracorporeal membrane oxygenation: is antibiotic prophylaxis necessary? (Abstract). Crit Care Med 38(Suppl):A176, 2010.
12. Sun HY, Ko WJ, Tsai PR, et al: Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg 140: 1125-1132.e2, 2010.
13. Aubron C, Cheng AC, Pilcher D, et al: Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome. Infect Control Hosp Epidemiol 34: 24-30, 2013.
14. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Ann Arbor, MI, USA, Extracorporeal Life Support Organization, 2013.
15. Y ilmaz G, Koksal I, Aydin K, Caylan R, Sucu N, Aksoy F: Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. JPEN J Parenter Enteral Nutr 31: 284-287, 2007.
16. OHoro JC, Silva GL, Munoz-Price LS, Safdar N: The efficacy of daily bathing with chlorhexidine for reducing healthcare-Associated bloodstream infections: a meta-Analysis. Infect Control Hosp Epidemiol 33: 257-267, 2012.
17. Safdar N, OHoro JC, Ghufran A, et al: Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-Analysis. Crit Care Med 42: 1703-1713, 2014.